Atlas Trials

A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects

Clinical trial NCT00134199 · COMPLETED

Trial details

NCT number
NCT00134199
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Obesity
Start date
2005-03-01
Enrollment
282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.